Welcome to our dedicated page for Fortive news (Ticker: FTV), a resource for investors and traders seeking the latest updates and insights on Fortive stock.
Fortive Corporation (NYSE: FTV) is an industrial technology company with strategic segments in Intelligent Operating Solutions and Advanced Healthcare Solutions. The Fortive news feed on Stock Titan aggregates company announcements, segment updates, and disclosures that illustrate how Fortive’s businesses operate across industrial measurement, calibration, and healthcare infection prevention.
Investors and observers can find news about Fortive’s earnings releases, including quarterly results and guidance updates, along with details on segment performance for Intelligent Operating Solutions and Advanced Healthcare Solutions. The company also issues announcements regarding capital allocation, such as regular quarterly dividends and share repurchase authorizations approved by its Board of Directors.
News from Fortive’s operating companies provides additional context on its industrial and healthcare footprint. Fluke Corporation, which describes itself as a world leader in compact, professional electronic test tools and software for measuring and condition monitoring, publishes updates on software-as-a-service offerings like CalStudio and research into unplanned downtime in industrial manufacturing. These releases shed light on how Fluke supports technicians, engineers, and maintenance professionals in managing industrial, electrical, and electronic equipment and calibration processes.
Within healthcare, Advanced Sterilization Products (ASP) issues news on infection prevention technologies, such as the ULTRA GI Cycle for the STERRAD 100NX Sterilizer with ALLClear Technology. ASP’s announcements highlight developments in hydrogen peroxide gas plasma sterilization for complex devices like duodenoscopes and describe collaborations with medical device manufacturers and partners in Europe.
By following this news page, readers can review Fortive’s official communications on financial performance, strategic actions such as the separation of Ralliant Corporation, and product and technology updates from its key brands. The feed provides a centralized view of Fortive’s ongoing activities in industrial technology and healthcare solutions.
Advanced Sterilization Products (FTV) announced on Jan 15, 2026 that the ULTRA GI™ Cycle for the STERRAD™ 100NX Sterilizer with ALLClear™ Technology received CE mark approval in partnership with FUJIFILM Healthcare Europe. The cycle adds hydrogen peroxide gas plasma sterilization for duodenoscopes, including compatibility for FUJIFILM models ED-840T and ED-840XT. Existing STERRAD 100NX customers can obtain the ULTRA GI Cycle via a cycle upgrade on installed equipment, while ASP will work with device makers to design future duodenoscopes for hydrogen peroxide compatibility. The move aims to strengthen reprocessing confidence and patient safety across European healthcare settings.
ASP (NYSE: FTV) announced that the ULTRA GI™ Cycle for the STERRAD™ 100NX Sterilizer with ALLClear Technology has received CE mark approval, enabling validated hydrogen peroxide gas plasma sterilization for complex duodenoscopes across Europe. The ULTRA GI Cycle adds compatibility for FUJIFILM duodenoscope models ED-840T and ED-840XT, and current customers with a STERRAD 100NX with ALLClear can obtain the new cycle via a cycle upgrade on existing equipment. ASP said it will work with device manufacturers to promote broader hydrogen peroxide compatibility for future duodenoscope models, positioning the technology as a tool to improve reprocessing and patient safety.
Fortive (NYSE: FTV) will webcast its fourth quarter 2025 earnings conference call on Wednesday, February 4, 2026 at 12:00 p.m. ET. The call is expected to last approximately one hour and will include an accompanying presentation. Investors can access the live webcast and a digital replay via the Investors section of Fortive's website under News & Events, and materials will be posted under Financial Info. Dial-in numbers for the call are 877-407-3110 (U.S.) and +1 215-268-9915 (outside the U.S.).
Tolion Health AI (DVA) appointed Gregory J. Moore, MD, PhD, to its board on January 6, 2026, strengthening clinical, AI, regulatory, and global growth expertise.
Dr. Moore brings experience leading health and life-sciences teams at Microsoft and Google, board service at DaVita and Fortive, and academic and clinical credentials. Tolion highlighted its 2025 US launch of Tolion Brain Coach on the Apple App Store, recent fundraising, and US/Europe infrastructure growth. Near-term priorities include user growth, Apple Health interoperability, an Android release, Garmin integration, and partnerships with labs, health plans, and specialty providers.
Fluke (NYSE:FTV) on November 3, 2025 announced CalStudio, a SaaS calibration-management platform that centralizes procedures, data, and collaboration for calibration labs.
CalStudio uses the Cubyt technical database to provide web access to standardized, always-current methods, remove local installations, simplify procedure authoring with low-code drag-and-drop tools, and let technicians run authored procedures anywhere. A livestream about CalStudio is scheduled for November 5, 2025 at 12:00 PM ET.
Fortive (NYSE: FTV) announced that Olumide Soroye, President and Chief Executive Officer, will present at the Baird 2025 Global Industrial Conference on Tuesday, November 11, 2025 at 4:05 p.m. CT (5:05 p.m. ET).
The presentation audio will be webcast live and the archive will be available on www.fortive.com.
Fluke (FTV) — Oct. 30, 2025: Survey of 600 manufacturing leaders finds 61% experienced unplanned downtime in the past year, costing the sector up to $852M per week. Respondents report frequent incidents (48% report 6–10 weekly; 19% report 11–20 weekly) and long durations (45% up to 12 hours; 15% up to 72 hours). At an average cost of $1.7M per hour, a single incident can reach $42.6M in losses. Large enterprises show higher exposure. The survey highlights fragmented digital spending on predictive maintenance, digital twins, and condition monitoring.
Fortive (NYSE: FTV) reported Q3 2025 continuing-operations results: revenue $1.03B (+2.3% reported; core +1.9%), GAAP diluted EPS $0.35 (+9.4%) and adjusted diluted EPS $0.68 (+15.3%).
Adjusted EBITDA was $309M (30.1% margin, +10.4%). The company executed $1.0B of share repurchases (21M shares, ~6% of diluted shares) and raised full-year 2025 adjusted EPS guidance to $2.63–$2.67 from $2.50–$2.60. TTM GAAP operating cash flow was $1,019M and TTM free cash flow $922M. The press release notes the June 28 PT separation and that discontinued operations are excluded.
Fortive (NYSE: FTV) has scheduled its third quarter 2025 earnings conference call for Wednesday, October 29, 2025, at 12:00 p.m. ET. The one-hour call will be accompanied by a slide presentation and webcast on the company's investor relations website.
Participants can join via webcast at www.fortive.com under the "Investors" section, or by phone at 877-407-3110 (U.S.) or 215-268-9915 (international). A replay will be available through the website and by calling 877-660-6853 (U.S.) or 201-612-7415 (international) using Access ID: 13756329.
FAQ
What is the current stock price of Fortive (FTV)?
What is the market cap of Fortive (FTV)?
